AKT2 CLIA Kit
Kurzübersicht für AKT2 CLIA Kit (ABIN6201182)
Target
Alle AKT2 CLIA Kits anzeigenReaktivität
Nachweismethode
Methodentyp
Detektionsbereich
Applikation
Proben
-
-
Untere Nachweisgrenze
- 0.312 ng/mL
-
Analytische Methode
- Quantitative
-
Sensitivität
- < 0.114 ng/mL
-
-
-
-
Plattentyp
- Pre-coated
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Lagerung
- 4 °C
-
Informationen zur Lagerung
- Shipped at 4°C. Upon receipt, store the kit according to the storage instruction in the kit's manual.The stability of the kit is determined by the rate of activity loss. The loss rate is less than 5% within the expiration date under appropriate storage conditions. To minimize performance fluctuations, operation procedures and lab conditions should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same user throughout.
-
Haltbarkeit
- 6 months
-
-
- AKT2 (V-Akt Murine Thymoma Viral Oncogene Homolog 2 (AKT2))
-
Andere Bezeichnung
- Protein Kinase B beta (PKBb)
-
Pathways
- PI3K-Akt Signalweg, RTK Signalweg, AMPK Signaling, TLR Signalweg, Cellular Glucan Metabolic Process, Regulation of Carbohydrate Metabolic Process, Hepatitis C, VEGF Signaling
Target Alle AKT2 CLIA Kits anzeigen
-